Examples of using Echinococcus in English and their translations into Hungarian
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Financial
-
Programming
-
Official/political
-
Computer
At the larval stage, the echinococcus continues to grow and develop in the human body.
This type of worms includes cestodes, dwarf tapeworm,tapeworm, and echinococcus.
In addition, echinococcus can spread to bone, brain, lungs and other organs, causing a violation of their functions.
Dogs travelling to Finland, Ireland, Malta,the UK or Norway must be treated against the Echinococcus multilocularis tapeworm.
The implementation of a programme for the eradication of the Echinococcus multilocularis parasite in wild definitive host animals, within a defined timescale.
Parasite Echinococcus exclusively in the human body in the form of larvae, affecting not only the liver, but other organs such as brain and lungs.
Dogs moving directly between Norway, Finland, Ireland, orthe United Kingdom to Malta are exempted from the treatment against the tapeworm Echinococcus multilocularis.
The occurrence of any Echinococcus multilocularis infection in definitive host animals has been detected during the surveillance periods referred to in Article 5(3); or.
If you take an animal into Finland, Ireland, Malta or the United Kingdom,it must be treated against the tapeworm Echinococcus as follows.
Due to the hooks on his body, echinococcus is attached to the walls of the intestinal mucosa, after which, together with the bloodstream, is transferred to the portal system.
Review this Regulation no later than 5 years following the date of its entry intoforce in the light of scientific developments regarding Echinococcus multilocularis infection in animals;
It is caused by the larval stages of the tapeworm Echinococcus multilocularis(EM) whose definitive host is usually the red fox, while arvicolid rodents act as intermediate hosts.
Supplementing Regulation(EC) No 998/2003 of the European Parliament andof the Council as regards preventive health measures for the control of Echinococcus multilocularis infection in dogs.
According to the EFSA's opinion of 2006,the shedding of infectious eggs of the Echinococcus multilocularis parasite does not commence until 28 days after ingestion of an infected intermediate host.
While Echinococcus multilocularis infection in animals occurs in the northern hemisphere, including central and northern parts of Europe, Asia and North America, it has never been recorded in domestic and wild definitive hosts in certain areas of the European Union despite ongoing surveillance of wildlife and unrestricted access of dogs.
Member States listed in Annex I shall immediately notify to the Commission andthe other Member States the detection of any Echinococcus multilocularis infection in samples taken from wild definitive host animals.
The preventive health measures for the control of Echinococcus multilocularis infections in dogs should therefore consist in the documented administration by a veterinarian of an effective authorised or licensed medicinal product which guarantees the timely elimination of the intestinal forms of the Echinococcus multilocularis parasite.
Pharmacologically active substances, which alone or in combination, havebeen proven to reduce the burden of mature and immature intestinal forms of the Echinococcus multilocularis parasite in the host species concerned;
This Regulation establishes preventive health measures for the control of Echinococcus multilocularis infection in dogs intended for non-commercial movements into the territories of the Member States or parts thereof.
The current transitional regime, established by regulation 998/2003, authorises Finland, Ireland, Malta, Sweden and the United Kingdom to make the entry of pet animals into their territory subject to compliance withcertain additional requirements until 30 June 2010, in order to prevent the risk of introducing rabies, echinococcus and ticks.
Considering that the preventive health measures are burdensome,they should be applied proportionately to the risk of the spread of Echinococcus multilocularis infection through the non-commercial movements of pet dogs.
This Regulation establishes preventive health measures for the control of Echinococcus multilocularis infection in dogs intended for non-commercial movements into the territories of the Member States or parts thereof, which are determined on the basis of.
They have implemented, for three 12-month periods prior to the date of that application, a pathogen-specific surveillance programme which complies with the requirements of Annex II andhas not recorded any occurrence of Echinococcus multilocularis infection in wild definitive host animals, and such occurrences are compulsorily notifiable under national law.
Sweden has reported cases of Echinococcus multilocularis infection in wildlife since January 2011, while Ireland, Finland and the United Kingdom have submitted to the Commission results of their surveillance for the Echinococcus multilocularis parasite in wild definite hosts which support their claim of the absence of the parasite in their respective ecosystems.
After the first 24-month period following the beginning of the compulsoryprogramme provided for in Article 4 for the eradication of Echinococcus multilocularis infection in wild definitive host animals in Member States or parts thereof listed in Part B of Annex I.
Given the experience of some other Member States which permit a longer treatment window under national rules in accordance with Article 16 of Regulation(EC) No 998/2003 and have remained free from the parasite, a reasonable increase in that treatment window to a 24 to 120 hour period should not significantly enhance the risk ofre-infection of treated dogs from endemic areas with the Echinococcus multilocularis parasite.
During the 15 years prior to the date of that application and without applying a pathogen-specific surveillanceprogramme they have not recorded any occurrence of Echinococcus multilocularis infection in host animals provided that during the 10 years prior to the date of that application the following conditions have been met.
Malta has submitted evidence that suitable definitive wildlifehost animals are missing on the island, that the Echinococcus multilocularis parasite has never been recorded in indigenous domestic definitive hosts and that the environment does not support a significant population of potential intermediate host animals.
They have implemented, for three 12-month periods prior to the date of that application, a pathogen-specific surveillance programme which complies with the requirements of Annex II andhas not recorded any occurrence of Echinococcus multilocularis infection in wild definitive host animals, and such occurrences are compulsorily notifiable under national law.
On each occasion within 24 to 48 hours before check-in with the approved transport company, dogs and cats travelling or returning to the UK6 orIreland7 must be treated by a veterinarian against the tapeworm Echinococcus multilocularis by administering, in accordance with the manufacturer's instructions, a product containing praziquantel.